Aqueous Extract of Bacopa procumbens and the NAPEL Formulation Mitigate MPTP-Induced Neurotoxicity via Nrf2/HSF1/HIF-1α Signaling in a Parkinson’s Disease Model
Authors:
- Maribel Pérez-RodríguezMPMaribel Pérez-Rodríguez
- Salvador Pérez-MoraSPSalvador Pérez-Mora
- Marvin A. Soriano-UrsúaMarvin A. Soriano-Ursúa
- María del Consuelo Gómez-GarcíaMGMaría del Consuelo Gómez-García
- Yazmin Montserrat Flores-MartinezYazmin Montserrat Flores-Martinez
- Juan Ocampo-LópezJOJuan Ocampo-López
- Absalom Zamorano-CarrilloAZAbsalom Zamorano-Carrillo
- José Manuel Viveros-BartoloméJosé Manuel Viveros-Bartolomé
- David Guillermo Pérez-IshiwaraDavid Guillermo Pérez-Ishiwara
Open Access
- 10 December 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 11914
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron degeneration in the substantia nigra and striatum. Current treatments are largely palliative and frequently associated with adverse effects. This study aimed to evaluate the neuroprotective potential of an aqueous extract of Bacopa procumbens (B. procumbens) and the NAPEL formulation—composed of five neuroactive compounds (Naringenin, Apigenin, Paeoniflorin, (−)-Epicatechin, and Lupeol)—in a murine model of MPTP-induced parkinsonism. Behavioral, histological, and molecular parameters were examined to elucidate underlying mechanisms of neuroprotection. Male mice received MPTP to induce parkinsonism, followed by oral administration of B. procumbens extract or NAPEL. Motor function was assessed through open-field-related parameters. Substantia nigra neuronal morphology was analyzed histologically. Molecular analyses focused on the Keap1/Nrf2/ARE pathway, HSF1, HIF-1α, antioxidant enzymes, and lipid peroxidation. Additionally, in silico analyses (GeneMANIA, STRING) were performed to explore regulatory networks associated with Nrf2, HSF1, and HIF-1α. The aqueous extract significantly improved motor performance, increased rearing events, enhanced central exploration, and increased total distance traveled. It preserved neuronal number and soma diameter in the substantia nigra. Molecularly, the extract activated the Keap1/Nrf2/ARE axis and induced HSF1 and HIF-1α, accompanied by increased SOD-1, CAT, and GSR expression and reduced lipid peroxidation. NAPEL also produced behavioral and histological improvements but did not activate Nrf2, HSF1, or HIF-1α nor notably elevate antioxidant enzymes, except for CAT in the striatum. In silico analyses identified Nrf2, HSF1, and HIF-1α as central nodes integrating oxidative stress, proteostasis, hypoxia, inflammation, and apoptotic responses. These findings support the neuroprotective potential of both B. procumbens aqueous extract and the NAPEL formulation, highlighting their value as promising therapeutic candidates for Parkinson’s disease.Keywords
Funding Information
- Instituto Politécnico Nacional (20221123, 20254934)
This publication has 78 references indexed in Scilit:
- Unrevealing the molecular mechanisms of MPTP-induced Parkinson’s in experimental animalsMedicinal Chemistry Research, 2025
- Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine modelActa Neuropathologica, 2025
- Unraveling neuroprotection in Parkinson’s disease: Nrf2–Keap1 pathway’s vital role amidst pathogenic pathwaysInflammopharmacology, 2024
- The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A reviewAgeing Research Reviews, 2024
- Activation of Nrf2 by methylene blue is associated with the neuroprotection against MPP+ induced toxicity via ameliorating oxidative stress and mitochondrial dysfunctionBiochemical Pharmacology, 2021
- NRF2 and HSF1 coordinately regulate heme oxygenase-1 expressionBiochemical and Biophysical Research Communications, 2018
- Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson’s diseaseCellular and Molecular Life Sciences, 2016
- Parkinson’s Disease2012
- Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic?Psychopharmacology, 2007
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976